ÂÜÀòÂÒÂ×

Manoja Eswara is an experienced professional in the field of cell and gene therapy, currently serving as a Senior Development Manager at CCRM since December 2017. Manoja manages and executes Fee-For-Service contract services, and is recognized as a subject matter expert in iPSC gene editing, allogeneic strategies, reprogramming, differentiation, and immunotherapy. Previously held positions include Development Manager and Development Scientist II, where Manoja led various projects in gene editing and cell therapies. Manoja's work at Lunenfeld-Tanenbaum Research Institute included postdoctoral research resulting in multiple publications on epigenetic regulation in cancer cells. Additionally, Manoja has experience in writing and editing and has academic teaching experience in molecular biology. Educational qualifications include a PhD in Molecular and Cellular Biology from the University of Guelph and an MSc in Biotechnology from Andhra University.